Literature DB >> 31700835

Genetic Polymorphisms of Glutathione S-Transferases T1 (GSTT1) and M1 (GSTM1) in Iranian Mandaeans Population.

Fariba Boroumand1, Mahdis Zarghami1, Mostafa Saadat1.   

Abstract

Entities:  

Year:  2019        PMID: 31700835      PMCID: PMC6825671     

Source DB:  PubMed          Journal:  Iran J Public Health        ISSN: 2251-6085            Impact factor:   1.429


× No keyword cloud information.

Dear Editor-in-Chief

Glutathione S-transferases (GSTs; EC: 2.5.1.18) are ubiquitous enzymes which contribute to the protection against a varied range of harmful chemicals including carcinogens, drugs, pesticides and environmental pollutants (1). The GSTM1 (OMIM: 138350) and GSTT1 (OMIM: 600436) belong to mu and theta classes of the GST superfamily. Null alleles in these two genes have been well defined. The null alleles represent deletions of the corresponding genes and result in a loss of enzymatic activity (1). Studies indicated that these polymorphisms were associated with complex multifactorial trials (1–3). The GSTT1 and GSTM1 null genotypes showed variations between different ethnic groups (4–6). Numerous studies on genetic structure of Iranian populations indicate that Iran has one of the most heterogeneous populations of the world. Mandaean (a small and closed ethno-religious) community is one of the Iranian sub-populations. They strongly have a dualistic worldview. They migrated from Jordan/Palestine areas to southern Iraq and south-west Iran areas about 20 centuries ago. Mandaeans language belongs to Eastern Aramaic language (7). Very recently the prevalence of consanguinity among Iranian Mandaeans living in Khuzestan Province was reported (8). However, there is no published data about genetic structure of Mandaean population. Therefore, the present study was carried out to determine the frequency of the GSTT1 and GSTM1 null genotypes in Iranian Mandaeans. The total study subjects consisted of 119 (50 males, 69 females) healthy Mandaeans living in Khuzestan Province (south-west Iran) in 2016. The present study was approved by the Ethics Committee of Shiraz University. Written informed consent was obtained from each participant. The study was carried out in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki) for Ethical Principles of Medical Research Involving Human Subjects. Genomic DNA was extracted from whole blood using a salting-out method. Genetic polymorphisms for GSTT1 and GSTM1 were determined by multiplex PCR in which β-globin gene was co-amplified as an internal control (5, 6). Since there was no statistically significant difference between gender groups for the study polymorphisms, the sex groups were pooled. The null genotypes of GSTT1 and GSTM1 was 16.0% (95% CI: 9.3%–22.7%) and 76.5% (95% CI: 68.7%–84.3%), respectively. The GSTM1 null genotype in other Iranian ethnic groups has been reported about 41%–58% (5, 6), which revealed highly significant differences with Iranian Mandaeans. About 20 century ago, Mandaeans migrated from Jordan/Palestine areas to Iraq and Iran (7). Therefore, their gene pool was separated from their origins for about 20 centuries. During this period, evolutionary forces might have some effects on Mandaeans’ gene pool. The frequency of the GSTM1 null genotype among Jordanian, Palestinian, Ashkenazi Jews and non-Ashkenazi Jews was 27.1%, 56.0%, 55.2%, and 55.2% (9, 10), respectively. On the other hand, the frequency of the GSTT1 null genotype among Jordanian, Palestinian, Ashkenazi Jews and non-Ashkenazi Jews was 24.2%, 22.0%, 26.0%, 22.1% (9, 10), respectively. Comparisons between Iranian Mandaeans and above-mentioned populations demonstrating that Mandaeans showed higher and lower levels of the GSTM1 and GSTT1 null genotypes, respectively. There was remarkably difference between Mandaeans and other mentioned populations for the frequency of the GSTM1 null genotype. Mutation, gene flow and natural selection should be disregarded in interpretation the influence of evolutionary forces on Mandaeans and their surrounding gene pools. In Iran and Iraq Mandaeans lived as small and isolated ethno-religious communities. Therefore, genetic drift, at least in part might be account for differences between Mandaeans and other populations.
  8 in total

1.  CYP1AI, glutathione S-transferase gene polymorphisms and risk of Polycythemia vera.

Authors:  Randa G Naffa; Abdalla S Awidi; Al-Motassem F Yousef; Said I Ismail
Journal:  Cancer Epidemiol       Date:  2011-10-21       Impact factor: 2.984

2.  Association between null alleles of GSTM1 and GSTT1 and dependence to heroin and opium.

Authors:  Mohammad Rashid Khalighinasab; Khyber Saify; Mostafa Saadat
Journal:  Psychiatry Res       Date:  2015-05-12       Impact factor: 3.222

3.  CONSANGUINEOUS MARRIAGES AMONG IRANIAN MANDAEANS LIVING IN SOUTH-WEST IRAN.

Authors:  Mostafa Saadat; Mahdis Zarghami
Journal:  J Biosoc Sci       Date:  2017-06-06

Review 4.  Glutathione S-transferase polymorphisms and their biological consequences.

Authors:  J D Hayes; R C Strange
Journal:  Pharmacology       Date:  2000-09       Impact factor: 2.547

5.  Non-Jewish Israeli IBD patients have significantly higher glutathione S-transferase GSTT1-null frequency.

Authors:  Amir Karban; Norberto Krivoy; Hela Elkin; Lior Adler; Yehuda Chowers; Rami Eliakim; Edna Efrati
Journal:  Dig Dis Sci       Date:  2011-01-18       Impact factor: 3.199

6.  Glutathione S-transferase genetic polymorphisms (GSTM1, GSTT1 and GSTO2) in three Iranian populations.

Authors:  Laleh Rafiee; Iraj Saadat; Mostafa Saadat
Journal:  Mol Biol Rep       Date:  2009-05-10       Impact factor: 2.316

7.  Association of glutathione S-transferase M1 and T1 polymorphisms and temperament.

Authors:  Zahra Zendehboodi
Journal:  Mol Biol Res Commun       Date:  2017-09

8.  Prevalence of Null Genotypes of Glutathione S-Transferase T1 (GSTT1) and M1 (GSTM1) in Seven Iranian Populations.

Authors:  Gholamreza Nasseri; Tahereh Zahedi; Fatemeh Mousavi-Kazerooni; Mostafa Saadat
Journal:  Iran J Public Health       Date:  2015-12       Impact factor: 1.429

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.